Texas Society of Health-System Pharmacists
Neonatal & Pediatrics Conference
#Peds2019
OCTOBER 25-27, 2019 JW MARRIOTT HOUSTON BY THE GALLERIA
Supporting Those Who Serve Our Youngest Patients
TABLE OF CONTENTS Important Information.............. 2-3 Conference Maps .............................. 4 Must-See Events .............................. 5 Schedule of Events ................... 6-10 2019 Exhibitors....................... 12-13
Conference Goals and Objectives
The overall educational goal of this meeting is to provide information and instruction on a variety of topics to enable the pharmacy practitioner to provide quality patient care. Pharmacist and Technician registrants may select from a total selection of 20 hours of programming; a total of 14 hours may be acquired. To obtain CPE credit, you must be a paid registrant for the 2019 TSHP Neonatal & Pediatrics Conference and complete the online CPE Credit Request and Evaluation for each session attended no later than December 9, 2019 via the TSHP Education Portal (https://tshp.wcea.education/). Educational programs at this meeting were designed to meet the needs of practitioners in a variety of settings, including large and small hospitals that serve the pediatric population. The educational programs were developed to maintain and enhance the knowledge, skills, and abilities of pharmacists and pharmacy technicians in health care systems through instruction and workshop sessions on important issues relevant to contemporary pharmacy practice.
Texas Society of Health-System Pharmacists 3000 Joe DiMaggio Blvd, Ste 30A Round Rock, Texas 78665-3920 Ph: (512) 906-0546 • Fax: (512) 852-8514 tshp@tshp.org • www.tshp.org
CPE Credit
By rule of the Texas State Board of Pharmacy, pharmacists may not utilize programming designed for pharmacy technicians to apply towards their license renewal. However, all attendees are encouraged and welcome to participate in any educational program offered during the Conference.
TSHP2019-2020 Officers President - Steven Knight Immediate Past President - Tammy Cohen President-Elect - Sarah Lake-Wallace Secretary - Latresa Billings Treasurer - Randy Martin President-Elect Designee - Latresa Billings Secretary-Elect Designee - Mallory Gessner-Wharton
Continuing education programming that is designed for technicians must have educational goals and learning objectives that indicate what a technician can expect to learn from participating in the session. These are filed with ACPE and carry a “T” designation at the end of the Universal Activity Number (UAN) [e.g., 0156-0000-19-076-L04-T]. The Texas Society of Health-System Pharmacists is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. Documentation of attendance at individual CPE session is accomplished via the TSHP Educational Portal no later than December 9, 2019.
Neonatal & Pediatrics Conference Task Force Clair Latiolias, Chair Jordan Burdine Lois Kim Julie Krapfel Kathryn Merkel Prem Oommen Curtis Petty Denise Pinal Jeff Wagner Wesley Wells
The sessions during the Conference are designed as either Knowledge-based or Application-based, depending on the educational content and teaching approach offered by the presenter.
All speakers, unless otherwise indicated, have no relevant conflicts of interest to disclose. Speakers that have indicated a potential conflict have had their educational content peerreviewed to ensure no bias is included.
TSHP Staff Stacey Mather, CAE - Executive Director Leah Cody - Professional Development Manager Katha Ferguson - Office Manager/Bookkeeper Rebecca O’Connor - Advocacy & Practice Director Jenni Peters - Membership & Communications Manager Claudia Pompa - Professional Development Coordinator 2
IMPORTANT INFORMATION Education Planning & Application
Special Assistance
Topics selected for the 2019 TSHP Neonatal & Pediatrics Conference were developed by the TSHP Neonatal & Pediatrics Conference Task Force based upon input from TSHP members. Additionally, input was obtained from the various specialty Sections of TSHP, affiliated local chapters, the TSHP Board of Directors, and from review of surveys of other state societies of health-system pharmacists of their member’s needs.
If you have any disability for which you require an auxiliary aid or special service while attending the Conference, please contact the TSHP Registration Desk. Consult the Registration Desk if you have any dietary restrictions that should be noted for food events. Dietary accommodations require 72-hour prior notice.
Children
For health and safety considerations, children under the age of 16 will not be admitted to the exhibits, or educational programs.
HOW DO I GET MY CPE CREDIT? • Each session accredited for CPE is included in TSHP’s Education Portal (https://tshp.wcea.education/). • You must indicate your participation in each session, through the use of a “live session code.” A separate code will be provided for pharmacists and technicians. • The credit requests and evaluations must be completed no later than December 9 in order to receive credit. • Paper statements of credit will NOT be provided. • Credit uploads are automatically sent to the My CPE Monitor system and should appear in your profile within 24-72 hours after completion. Transfer of credit to My CPE Monitor depends on accurate NABP ePID and birth date data in your TSHP Education Portal profile.
Registration/Customer Service
The TSHP Registration/Customer Service Desk, staffed by TSHP personnel, is located in the conference center, 2nd Floor. A diagram of the facilities are included in this program on page 4 and an interactive version is available through the “TSHP Events” app.
Going Green
In an effort to be more ecologically responsible, this program and presentation handouts will not be available in printed format. These materials are available on the TSHP website (www.tshp. org) for download and print or through the “TSHP Events” app. Thank you for your support.
Registration
Full registration includes all meeting sessions, meals, ans networking events.
Badges
TSHP Events App
Badges should be worn at all times. Your badge is your admission pass for all meeting sessions, exhibits, and social events. Reminder: Take a moment and write emergency contact information on the back of your name badge, especially if you have medical conditions that may require attention during the meeting.
Cancellation, No-Show, and Refunds
All requests for refunds must have been made in writing by October 11, 2019. At this time no refunds will be offered. No-show attendees will not be given a refund and a no-show registrant with a balance due will be expected to complete payment. No attendee with a balance due will be allowed admittance nor issued CPE credit.
Download it now in the Apple App Store or Google Play store. Search “TSHP Events”
#PharmacyStrong #Peds2019 3
MAPS All conference rooms are at the JW Marriott Houston by The Galleria unless otherwise noted in the agenda. Consult this program or the interactive “TSHP Events� app for specific meeting rooms and event locations.
JW Marriott Houston by The Galleria
Second Floor
First Floor
4
MUST-SEE EVENTS All events located in the Grand Ballroom unless otherwise noted.
Pediatrics Primer Workshop* Sunday, October 25 12:30 PM - 6:00 PM Room: Hidalgo
Welcome & Keynote Breakfast Saturday, October 26 7:30 AM - 6:00 AM
Lunch with Exhibitors Saturday, October 26 11:15 AM - 1:00 PM
Networking Refreshment Break Saturday, October 26 3:00 PM - 4:00 PM
Networking Reception Saturday, October 26 5:00 PM - 7:30 PM
Breakfast
Sunday, October 27 7:00 AM - 9:00 AM
Lunch with Exhibitors Sunday, October 27 11:15 AM - 1:00 PM
Texas Children’s Hospital Tour* Sunday, October 27 1:00 PM - 4:00 PM Meet in the hotel lobby at 1:00 PM.
Questions? Visit the Registration/Badge Pick-Up desk. *Additional fee event. See registration desk for details.
Pharmacy Leaders. Transforming Patient Care.
A Special Thank You to all our Members & Volunteers!
TSHP is #PharmacyStrong because of your service and leadership. 5
CONFERENCE SCHEDULE All room locations are on the 2nd Floor of the hotel conference center unless otherwise noted.
For full CE information (UAN numbers, objectives, CEUs), please visit the www.tshp.org/peds or the TSHP Events app – available in the Apple App Store or Google Play Store.
CATEGORY LEGEND F Foundational
O A
Operational Advanced Clinical
FRIDAY, OCTOBER 25, 2019
General Pediatrics 101 Pharmacists must be knowledgeable with pediatrics in order to provide optimal patient care. This session will discuss general pediatric definitions, common medication errors associated in these populations, and best practices to care for pediatric patients. This session will also cover lessons learned from practicing in the largest freestanding pediatric hospital in the nation.
Registration & Badge Pick-Up
11:00 AM - 6:00 PM...........................................Location: Hidalgo Foyer
Pediatric Primer Workshop* 12:30 PM - 6:00 PM ............................................................ Room: Hidalgo Compounding Medications for Pediatric Patients Learn about compounding for pediatrics from birth to adult and the challenges practitioners face.
Stephen J. Davis, PharmD, MS, FASHP Director, Health System Strategy Shields Health Solutions Houston, Texas
Lisa D. Ashworth, BS Pharm, RPh, FACA Compounding Specialist and Clinical Pharmacist Children’s Health System of Texas Dallas, Texas
*Additional registration required. Participants must attend all portions of the workshop to receive CPE credit.
Myths and Facts of Pediatric Pharmacotherapy This session will provide the audience with an introduction to general concepts of pediatric pharmacotherapy that influence medication use in this unique population. The presentation will review developmental differences observed in the pediatric patient compared to the adult patient. The audience will be presented with patient cases and asked to identify relative and absolute contraindications to medication therapy in the pediatric population using knowledge of any developmental differences. The patient cases will explore common diseases states encountered in the pediatric population so that the audience gains confidence in making appropriate drug therapy recommendations across a wide range of ages in the pediatric population.
SATURDAY, OCTOBER 26, 2019 Registration & Badge Pick-Up
7:00 AM -5:00 PM.............................. Location: Grand Ballroom Foyer
Welcome & Keynote Breakfast
7:30 AM - 9:00 AM...............................................Room: Grand Ballroom
F
KEYNOTE: Emily Jerry’s Story: From Heartbreak to Victory - Saving Lives by Preventing Errors Before They Happen! Ever since Emily Jerry’s tragic death, over 13 years ago from a preventable medication error, Chris began a very unintentional quest, he has always believed was chosen for him, to work diligently to affect positive change in medicine. Consulting with some of the brightest minds in healthcare, he has helped to transform the culture of medicine, how it is practiced in the U.S., and more importantly how we respond and learn from these preventable errors which have now been identified as being the third leading cause of death in the United States . Chris founded the Emily Jerry Foundation, in honor of his daughter’s name, to focus attention on the underlying systems, processes, and protocols in medicine, and to find comprehensive solutions that minimize this inherent “human error component of medicine.” Following Emily’s tragic medication error, he identified where and how the human error occurred and, subsequently, found solutions to prevent this from ever happening again. The foundation began in August of 2009 in the state of Ohio shortly after the passage of “Emily’s Law”.
Kathryn Givens Merkel, PharmD, BCPS, BCIDP, BCPPS Clinical Pharmacy Manager St. David’s South Austin Medical Center Austin, Texas
Multimodal Pain Management on Sickle Cell Patients with Acute Pain Crisis Severe acute pain is the most common manifestation of the Sickle Cell Disease. However, pain management is only one of a multitude of complications that accompanies a pain crisis. However, multimodal pharmacological and non-pharmacological treatment has help reduce patient’s pain score in the hospital and at home. Chi Pham‐Peyton, PharmD, BCPPS Pediatric Clinical Pharmacist Memorial Hermann, Memorial City Houston, Texas
6
Christopher S. Jerry President & CEO Emily Jerry Foundation for Patient Safety
TSHP Neonatal & Pediatrics Conference 9:00 AM - 10:00 AM............................Concurrent Sessions
Sarah Kubes, PharmD, BCPS Clinical Assistant Professor and Pediatric Clinical Specialist Pharmacist UT College of Pharmacy and University Health Systems Austin, Texas
Snakes and Spiders and Raccoons, Oh My! Treating Animal Bites in the Pediatric Emergency Department Room: Bexar/Travis/Nueces This presentation will cover pharmacotherapy options for animal bites, including bites from mammals, snakes, and spiders, in addition to stings from caterpillars, scorpions and jellyfish. Discussion of rabies prophylaxis, bite-related skin & soft tissue infection prophylaxis and treatment, rabies virus treatment options, procedures to obtain rare snake antivenins, key compounding points for antivenins and non-pharmacologic care of jellyfish and caterpillar stings will additionally be addressed.
F
O
Hillary Orr, PharmD Pediatric Clinical Pharmacy Specialist Pediatric/Cardiovascular Intensive Care Unit & Antimicrobial Stewardship Children’s Memorial Hermann Hospital Houston, Texas
Just a Matter of Time: Every Second Counts with Neonatal Sepsis Room: Hidalgo/Navarro Neonatal sepsis is one of the leading causes of morbidity and mortality in term and preterm infants. In this program, we will discuss strategies to reduce unnecessary antibiotic exposure to those neonates in the early part of their lives. Specifically, we will review literature on the use of neonatal sepsis calculators and determine the optimal “rule-out” sepsis antibiotic duration.
A
Courtney Kain, PharmD, MS, BCPPS Clinical Pharmacy Specialist Texas Children’s Hospital West Campus Houston, Texas
The Next Phase in Automation: IV Robotics with Smart Pump Technology Room: Hidalgo/Navarro Ongoing advances in pharmacy technology provide opportunities to improve the quality of care and the patient safety of IV compounded products administered by smart pumps. Many considerations must be taken into account during the assessment and implementation of these technological enhancements. IV robotics and smart pump interoperability complement each other in promoting safer preparation and administration of medications when dispensed as standardized volumes from automated dispensing cabinets.
Jessica Jacob, PharmD, BCPPS Clinical Pharmacy Specialist Pediatrics and the Neonatal Intensive Care Unit Hendrick Medical Center Abilene, Texas
Lunch with Exhibitors
11:15 AM - 1:00 PM.............................................Room: Grand Ballroom Network with pediatric providers and learn about the products and services offered by our exhibitors. With tables designated by a participating exhibitor, choose to sit at a table for a product you are already familiar to share your experiences and ask questions or learn about something entirely new. Then stroll around the ballroom—cake in hand—visiting exhibitors you haven’t met yet. Take your time and enjoy learning about products and services, while connecting with practitioners that share your interests.
Eric Espineli, PharmD, RPh Pharmacy Informaticist Texas Children’s Hospital Houston, Texas Jennifer Randazzo, RPh Pharmacy Informaticist Texas Children’s Hospital Houston, Texas
1:00 PM - 2:00 PM...............................Concurrent Sessions
F
Thinning the Herd: Anti-Vaccination Psychology Room: Bexar/Travis/Nueces This continuing education activity will provide a comprehensive review of the history of anti-vaccination sentiments of the 1800s through the recession of anti-vaccine thinking in the 1940s through 1970s and subsequent rise in the anti-vaccination movement. This activity will address reasons for parental vaccine refusal, use concepts from psychology to amplify understanding of parental confidence gaps leading to vaccine refusal, and suggest strategies to assist pharmacists when discussing these issues with vaccine-hesitant or –resistant parents.
10:05 AM - 11:05 AM.........................Concurrent Sessions
A
The Scary Truth About Gram-negative Bacterial Resistance and New Agents to Treat Them Room: Bexar/Travis/Nueces Antimicrobial resistance has been increasing globally and has reached a point that the World Health Organization (WHO) identifies as a major threat to humanity. In the United States, data from the Centers for Disease Control and Prevention suggest that more than 2 million infections each year are caused by resistant organisms and that antimicrobial resistance is blamed for 23,000 deaths annually. Some common mechanisms of Gram-negative antimicrobial resistance include the production of enzymes that degrade antibiotics (e.g., beta-lactamases); upregulation or reduction of membrane porins that reduce intracellular drug concentrations; or modifications to the target binding site. Newer antimicrobial agents that have been introduced to market (e.g., aztreonam/avibactam, cefiderocol, eravacycline, and ceftolozane/tazobactam plazomicin, to name a few), but what is their role in pediatrics?
Sara Liechti, PharmD Clinical Pharmacy Specialist Texas Children’s Hospital Houston, Texas
7
Emily Rodman, PharmD, BCPPS Clinical Pharmacy Specialist Texas Children’s Hospital Houston, Texas
CONFERENCE SCHEDULE Cystic Fibrosis: Modulating the Future of Disease Progression Room: Hidalgo/Navarro This presentation will provide a brief background on the pathophysiology of cystic fibrosis, the symptoms of the disease, and the standard treatments to treat the symptoms. The focus of the presentation will be regarding the data surrounding the use of cystic fibrosis transmembrane conductance regulator modulators: their mechanism of action, place in treatment, and outcomes. Lastly, the affect that these new medications have on disease progression will be discussed.
A
products to formulary. The aim of this presentation is to review the use of lipid emulsions in neonatal and pediatric patients, while comparing the three main lipid products available on the market and their utility in these patient populations.
O
Play to Your Strengths: Developing a Pediatric Rotation in a Non-Traditional Setting Room: Hidalgo/Navarro This presentation will discuss opportunities to develop pediatric IPPE and APPE rotations in communities that lack large pediatric institutions. Examples will be drawn from a pediatric APPE rotation through TTUHSC Jerry H. Hodge School of Pharmacy in Abilene, Texas. This rotation includes experiences across a breadth of pediatric practice sites, including the NICU and pediatric units of a regional medical center, a pediatric spe-
Erin J. McDade, PharmD, BCPPS Assistant Director - Clinical Pharmacy Services and Outcomes Texas Children’s Hospital Houston, Texas
2:05 PM - 3:05 PM ..............................Concurrent Sessions
O
Little People Problems in a Big World: USP 800 Implementation Room: Bexar/Travis/Nueces The purpose of this presentation will be to review USP 800 regulations affecting pediatric hospital pharmacies. During this presentation we will highlight some of the hardships and risks specific to pediatric hospitals with the implementation of USP 800. We will describe the challenges faced at Children’s Memorial Hermann Hospital, a children’s hospital within an adult hospital and large health system.
cialty outreach clinic, a pediatric primary care clinic, and
an independent compounding pharmacy. Faculty will describe the rotation structure, lessons learned, and how to maximize opportunities for students in a community hospital and ambulatory setting. Bethany W. Ibach, PharmD, BCPPS Assistant Professor Department of Pharmacy Practice Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy Abilene, Texas
Matthew Martin-Souza, PharmD Pediatric Clinical Pharmacist Children’s Memorial Hermann Hospital Houston, Texas
Chephra D. McKee, PharmD, BCPPS Assistant Professor of Pharmacy Practice Pediatrics Division Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy Abilene, Texas
Oncologic Emergencies in Pediatric Oncology Room: Hidalgo/Navarro In this session, participants will review the pathophysiology and risk factors of oncologic emergencies seen in the pediatric population. They will also evaluate approaches to the management and evaluation of children with oncologic emergencies, using a case-based approach. Important principles will be enforced through active participation of the audience in round-table discussion of cases and the potential therapeutic approach.
A
Networking Reception
5:00 PM - 7:30 PM .............................................. Room: Grand Ballroom
SUNDAY, OCTOBER 27, 2019
Brooke Bernhardt, PharmD, MS, BCOP, BCPPS Assistant Professor, Department of Pediatrics Section of Pediatric Hematology/Oncology Baylor College of Medicine Houston, Texas
Registration & Badge Pick-Up
7:00 AM - 1:00 PM ................................ Room: Grand Ballroom Foyer
Continental Breakfast
7:00 AM - 9:00 AM ............................................. Room: Grand Ballroom
Refreshment & Networking Break
8:00 AM - 9:00 AM .............................Concurrent Sessions
3:00 PM - 4:00 PM .............................................. Room: Grand Ballroom
F
4:00 PM - 5:00 PM ..............................Concurrent Sessions
F
Lipidpalooza: Which Lipid Emulsion Should I Choose? Room: Bexar/Travis/Nueces There has been a recent increase in the use of alternative lipid emulsion products in neonatal and pediatric parenteral nutrition. With recent Federal Drug Administration (FDA) approvals of a mixed lipid emulsion in 2016 and fish oil emulsion in 2018, many institutions are being asked by providers to add these
Jordan Burdine, PharmD, MBA, BCPPS Clinical Pharmacy Practice Specialist Pediatrics and Neonatology UTMB Health Galveston, Texas
8
Texas Well-Being: Promoting Well-Being in Various Learning Environments Room: Bexar/Travis/Nueces In this session, participants will learn about UT Austin Counseling Mental Health Center’s initiative to build collaborative relationships with faculty to support student mental health. They will learn how UT faculty have begun to create a learning community that decreases stressors, improves learning, builds student resilience, and helps students use specific wellness strategies and resources. Participants will walk away from this
TSHP Neonatal & Pediatrics Conference A
Staying Ahead of the Curve: AUC-Guided Dosing of Vancomycin Room: Hidalgo/Navarro Vancomycin is used for empiric therapy for suspected sepsis and is also considered the drug-of-choice for serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the pediatric population. The first consensus guideline endorsed by the American Society for Health-System Pharmacists, Infectious Diseases Society of America, and the Society for Infectious Diseases Pharmacists in 2009 outlined recommendations for vancomycin dosing and therapeutic monitoring in adults. Serum trough concentrations of 15-20 mg/L are utilized as a surrogate marker for optimal bactericidal activity based on in vivo pharmacokinetic and pharmacodynamic characteristics involving clinical efficacy, toxicity, and resistance. These guidelines do not address recommended dosing and monitoring recommendations for pediatric patients and there is little to no data on the safety and efficacy of targeted trough concentrations of 15-20 mg/L. Thus, a consensus statement and guideline endorsed by the American Society for Health-System Pharmacists, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and the Society for Infectious Diseases Pharmacists in 2019, encourages vancomycin AUC/ MICBMD ratio ≥ 400 as the currently accepted critical PK/PD index or “efficacy” target. With the near publication of these new guideline recommendations, it is both timely and essential to discuss the rationale for vancomycin AUC/MICBMD dosing, practical considerations for incorporating AUC/MICBMD dosing among pharmacist workflow and evaluate available Bayesian software programs.
session having learned and practiced specific wellness strategies that they can take back and embed in their work environments.
A
Thea Woodruff, PhD Lecturer & Well-Being in Learning Environments Coordinator UT Counseling and Mental Health Center Austin, Texas
Keeping it Legal: CBD Law Pharmacist Edition Room: Hidalgo/Navarro This 1-hour CE will focus on Texas pharmacy law as it relates to the prescribing and dispensing of CBD products. Attendants can expect to gain an understanding of both federal and state regulations regarding CBD products, as well as, pertinent pharmacologic properties of CBD-based medications. In addition, this presentation will also discuss professional challenges as they relate to the prescribing and dispensing of CBD products. Alexandra B. Ferrante, PharmD NICU/PICU Clinical Pharmacist Children’s Hospital of New Orleans New Orleans, Louisiana
9:05 AM - 10:05 AM ...........................Concurrent Sessions
O
Medication Safety Panel – Interventions to Reduce Pediatric Medication Error Room: Bexar/Travis/Nueces This session will serve to provide information for pharmacists and leaders with responsibility for medication safety oversight. The speakers will focus on several medication-related issues and initiatives from different health-systems that impact patient safety. The attendee will learn how to effectively select high-leverage strategies to sustain safety efforts within your organization.
Sarah Kubes, PharmD, BCPS Clinical Assistant Professor and Pediatric Clinical Specialist Pharmacist UT College of Pharmacy and University Health Systems Austin, Texas Hillary Orr, PharmD Pediatric Clinical Pharmacy Specialist Pediatric/Cardiovascular Intensive Care Unit & Antimicrobial Stewardship Children’s Memorial Hermann Hospital Houston, Texas
Sara J.D. Bork, PharmD, MBA Assistant Director – Medication Safety and Education Texas Children’s Hospital Houston, Texas
10:10 AM - 11:10 AM ........................Concurrent Sessions Caffeine in Premature Infants: Too Much of a Good Thing? Room: Bexar/Travis/Nueces Caffeine therapy has shown remarkable benefits beyond that of the short-term control of apneic events in premature infants. This has resulted in practitioners adopting changes in practice to initiate caffeine earlier with more aggressive dosing in an attempt to optimize the benefits in our most fragile patients.
A
Kimberly L. Dinh, PharmD Clinical Pharmacy Specialist – Medication Use and Policy Texas Children’s Hospital Houston, Texas
Weng Man Lam, PharmD, MS, BCPS, BCPPS Pediatric Critical Care/Cardiovascular Clinical Pharmacist Specialist II Children’s Memorial Hermann Hospital Memorial Hermann Texas Medical Center Houston, Texas
Chi Pham-Peyton, PharmD, BCPPS Clinical Practice Specialist, Pediatric/NICU/Pain Management Memorial Hermann Hospital, Memorial City Houston, Texas
Sherry Luedtke, PharmD, FPPAG Associate Professor of Pharmacy Practice Director of the Pediatric Specialty Residency Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy Lubbock, Texas
#Peds2019
9
CONFERENCE SCHEDULE O
Lessons Learned for Pediatric Specialty Pharmacy Room: Hidalgo/Navarro Specialty pharmacy continues to grow as the market is expected to double over the next five years. Specialty patients represent less than 5% of all patients, but account for 35% of total healthcare spending. As hospitals are looking to begin or expand their specialty pharmacy services, it is important to understand that it must be an organizational initiative for success. From a pediatric specialty pharmacy perspective, there are some unique challenges that will be discussed around implementation, accreditation, and best practices.
NOTES
Amy Alonzo, RPh, BCPPS Specialty Pharmacist – Project Specialist Texas Children’s Hospital Houston, Texas Stephen J. Davis, PharmD, MS, FASHP Director, Health‐System Strategy Shields Health Solutions Houston, Texas
Lunch with Exhibitors
11:15 AM - 1:00 PM ........................................... Room: Grand Ballroom
Texas Children’s Hospital Tour*
1:00 PM - 4:00 PM..................................................................... Hotel Lobby Round trip transportation provided. Meet in the hotel lobby at 1:00 PM. *Separate ticketed event. See registration form for details.
Members read for free at www.tshp.org/journal
Advancing Pharmacy Practice and Education in Texas
10
YEARS
10
Where are they now?
Mentees from the first TSHP Mentorship Program offer what the program has meant to them.
“For me, participating in the Mentorship Program 10 years ago allowed me to connect with a mentor who completed a similar career path in pharmacy leadership and helped me build my personal and professional connections that have continued in my career. My mentor provided great tips on how to stand out as a resident candidate, we discussed my CV, and he wrote my recommendation letters. Our mentor/mentee relationship continued after pharmacy school. My mentor helped me find my first management job when I completed residency. We are close friends today who I still reach out to ten years later!” Jerry James, PharmD, MS Director of Pharmacy | Dallas, TX “Being a part of the TSHP mentorship program has been a valuable experience for me to personally and professionally grow as an individual and a leader. My mentors help me to successfully navigate my journey. My way of giving back to my mentors and TSHP is that I have become a mentor to pay it forward to others.” Phuoc Anh (Anne) Nguyen, PharmD, MS, BCPS 2019 TSHP Pharmacy Mentor Award Recipient Pharmacy Manager | Houston, TX “I owe my mentor a big debt of gratitude! He was an informatics pharmacist so he was able to explain, in great detail, about the job and how the work he did was greatly beneficial for not only the healthsystem, but for the patients as well—you could really tell he was proud of the work he did. I’m an Informatics Pharmacist now myself. It didn’t happen right away though. I graduated, completed a PGY1-residency, and became a clinical pharmacist, but always had our conversations in the back of my mind. Fast forward a few years, I gravitated toward work on an upgrade from EHR to Epic and became a Super User, because my mentor told me what was possible. When a position came open on the Epic build team I jumped at the opportunity. If I never signed up for the TSHP Mentorship Program, I don’t think I would be in the position I am today. I want to tell my mentor, Thank You!” Brett R. Noteware, PharmD, MBA, BCPS Pharmacist Informatics & Information Management | Tyler, TX
TSHP Mentorship Program www.tshp.org/mentorship 11
EXHIBITORS Please visit our exhibitors in the Grand Ballroom. See page 5 for details.
Thank You to our 2019 exhibitors! Allergan Neurosciences
Chiesi Pharmaceuticals
Allergan is a world leader in neuromodulator therapy and neurosciences. For over two decades, we have been committed to the research and clinical development of BOTOX® (OnabotulinumtoxinA), one of the world’s most versatile medicines, to improve the physical well-being and resulting quality of life for people around the world who suffer from a variety of serious or debilitating disorders. BOTOX® is available in more than 75 countries with 20 approved indications.
Chiesi USA, Inc., headquartered in Cary, NC, is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Chiesi USA, Inc. is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. For more information, please visit www. chiesiusa.com or call our customer service department at (888) 466-6505.
Equashield
Equashield is a leading provider of a full range of manual and automated solutions to hospitals for the compounding and administration of hazardous drugs. Equashield’s product suite includes EQUASHIELD II, its flagship Closed System Transfer Device (CSTD), and EQUASHIELD® Pro, the first ever closed system drug compounding robot. Equashield’s CSTD is clinically-proven to protect healthcare professionals from hazardous drug exposure with its leak-proof, airtight, truly closed design.
Azurity
BTG International Plc.
BTG is a growing international specialist healthcare company bringing to market innovative products in specialist areas of medicine to better serve doctors and their patients. We have a portfolio of Interventional Medicine products to advance the treatment of liver tumors, emphysema, blood clots, and varicose veins, and Specialty Pharmaceuticals that help patients overexposed to certain medications or toxins. Inspired by patient and physician needs, BTG is investing to expand its portfolio to address some of today’s most complex healthcare challenges. To learn more about BTG, please visit: btgplc.com.
Fresenius Kabi
#PharmacyStrong
12
Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products are used to help care for critically and chronically ill patients. The people of Fresenius Kabi are driven by a common purpose to put lifesaving medicines and technologies in the hands of people who care for patients, and to find answers to the challenges they face.
EXHIBITORS Grifols USA
Pfizer Biosimilars
Grifols is a global healthcare company whose mission is to improve the health and well-being of people around the world. We have three primary divisions – Bioscience, Diagnostic and Hospital – that develop, produce and market our innovative products and services to medical professionals in more than 100 countries around the world.
Steri-Tamp® by Allied Pharmacy Products, Inc.
Allied Pharmacy Products, Inc. manufactures Steri-Tamp®, the most innovative single-use seals in hospital pharmacy today. Steri-Tamp®’s Vial Seals provide a 100% sterile barrier. Our non-sterile Tamper-Clear Syringe Seal® enables you to clearly see the markings on a syringe and scan any barcodes or labels. Steri-Tamp® has a patented dual-layer, so when the top layer is removed, an “OPENED” warning is left behind, providing true tamper-evidence. To learn more, please visit our website at www.steri-tamp.com.
Nephron Pharmaceuticals Corporation
Nephron Pharmaceuticals Corporation is a leading manufacturer of generic respiratory and 503B outsourcing medications. The company produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate their drug shortage needs. Licensed by the Food and Drug Administration, Nephron follows cGMP, GDP and all quality expectations. Nephron received a 2017 ISPE/FOYA innovation award for the high level of automation present throughout the facility. For more information, please visit www.nephronpharm.com.
Follow #Peds2019
TSHP Webinar Series Online and Home-study CPE Courses on Essential & Emerging Topics « Presented FREE to TSHP members »
13
Leave Your Student Loans Behind TSHP members receive a 0.125% rate discount when they refinance with Laurel Road.1
What is Student Loan Refinancing and Who is Eligible TSHP members can choose to refinance all or some of their federal and private loans from bachelor, and/or graduate degree programs. Laurel Road refinances student loans by paying off a customer's current student loans and issuing them a new loan. Laurel Road refinances student loans for pharmacists with degrees from accredited schools. Borrowers must be U.S. citizens or permanent residents. Loan eligibility depends on lending criteria such as your credit profile, monthly income, and monthly debt payments.
Why refinance? Student loan refinancing is an opportunity to: • Lower interest rate(s) and save money • Pay off loans faster
Member Benefit
• Lower monthly payments • Move from a fixed rate to a variable rate (or vice versa)
TSHP members receive a 0.125% rate discount when refinancing their student loans1
• Reduce number of loans in repayment
To learn more and apply, visit www.tshp.org/laurelroad 14
NOTES
Supporting the future of pharmacy in Texas through student pharmacist scholarships “The scholarship allowed me to focus on my studies and become more involved with my local and state chapter.” Rema Thyagarajan, PharmD, BCPS System Clinical Director of Pharmacy
Advancing Pharmacy since 1977
“With the cost of educa�on con�nuing to rise, the scholarships enabled me to concentrate less on the financial burden of educa�on and focus on my professional development.” Jordan Burdine, PharmD, MBA Clinical Prac�ce Specialist—Pediatrics
through education, research, and professional development
“I felt grateful that the Founda�on believed in me. The scholarship, along with my TSHP mentors, have been instrumental in molding me into the prac��oner I am today.” Bre� Noteware, PharmD, MBA, BCPS Applica�ons Coordinator, Informa�on Management
enabling the profession to better serve our patients and communities
“Receiving the scholarship engaged me more deeply with a group of people who would become my mentors and friends, helping shape my career and providing the opportunity to give back to other students, who will in turn, shape the future of the profession.” Traci L. (Me�ng) Holton, PharmD, MBA, FASHP Senior Director, Pharmacy & Medica�on Safety
www.tshp.org/foundation 15
SAVE THE DATE 2020 TSHP 2020 Annual Seminar April 17-19 Moody Gardens | Galveston, TX ®
www.tshp.org/seminar #tshp2020
#PharmacyStrong